Spero Therapeutics (SPRO) Stock: Buy, Sell, or Hold?

Valuation Analysis: SPRO is currently trading at $1.00, which is considered oversold relative to its 30-day fair value range of $1.04 to $1.17. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.5) compared to its historical average (6.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, SPRO is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $1.11.

Market Sentiment: SPRO scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Implied Volatility is high (82th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $5.33 (+433.4%). Current signals suggest waiting for a better entry point before initiating new positions.